Learning objectives: To recognize challenges in the development of clinical trials for frontline diffuse large B-cell lymphoma.
To appreciate new therapeutic strategies for improving outcomes in DLBCL.
10/12/2021 - 12:00pm to 1:00pm CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Christopher Flowers, MD